SANTAVAC Trademark

Trademark Overview

On Friday, September 16, 2016, a trademark application was filed for SANTAVAC with the United States Patent and Trademark Office. The USPTO has given the SANTAVAC trademark a serial number of 79199387. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, May 17, 2024. This trademark is owned by Obschestvo s ogranichennoj otvetstvennostyu "BIOBOGEMIYA". The SANTAVAC trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for medical purposes, namely, biological preparations for the prevention and treatment of cancer; medicines for human purposes, namely, medicinal preparations for the prevention and treatment of oncological diseases; pharmaceutical substances, namely, antigens for the prevention and treatment of oncological diseases; * pharmaceutical substances, namely, antigens for use in the manufacture of vaccines against cancer; pharmaceutical substances, namely, substances for use in the manufacture of vaccines against oncological diseases; * vaccines

General Information

Serial Number79199387
Word MarkSANTAVAC
Filing DateFriday, September 16, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, May 17, 2024
Registration Number5319461
Registration DateTuesday, October 31, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 15, 2017

Trademark Statements

Certificate of Correction for RegistrationIn the statement, line 8, after "diseases;" "pharmaceutical substances, namely, antigens for use in the manufacture of vaccines against cancer; pharmaceutical substances, namely, substances for use in the manufacture of vaccines against oncological diseases;" should be inserted.
Goods and ServicesBiological preparations for medical purposes, namely, biological preparations for the prevention and treatment of cancer; medicines for human purposes, namely, medicinal preparations for the prevention and treatment of oncological diseases; pharmaceutical substances, namely, antigens for the prevention and treatment of oncological diseases; * pharmaceutical substances, namely, antigens for use in the manufacture of vaccines against cancer; pharmaceutical substances, namely, substances for use in the manufacture of vaccines against oncological diseases; * vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 17, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBIOBOHEMIA, Inc.
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressUS
Party NameObschestvo s ogranichennoj otvetstvennostyu "BIOBOGEMIYA"
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressMoscow
RU
Party NameObschestvo s ogranichennoj otvetstvennostyu "BIOBOGEMIYA"
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMoscow
RU
Party NameObschestvo s ogranichennoj otvetstvennostyu "BIOBOGEMIYA"
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMoscow
RU

Trademark Events

Event DateEvent Description
Sunday, January 8, 2017NON-FINAL ACTION WRITTEN
Thursday, December 29, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, January 4, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 4, 2017ASSIGNED TO EXAMINER
Monday, January 9, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, January 10, 2017APPLICATION FILING RECEIPT MAILED
Friday, January 13, 2017REFUSAL PROCESSED BY MPU
Friday, January 13, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, February 3, 2017REFUSAL PROCESSED BY IB
Friday, February 24, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, March 12, 2017ASSIGNED TO LIE
Tuesday, March 21, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 21, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 7, 2017FINAL REFUSAL WRITTEN
Monday, April 10, 2017FINAL REFUSAL MAILED
Thursday, June 8, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, June 14, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 14, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 3, 2017TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, July 3, 2017PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, July 7, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 26, 2017NOTICE OF PUBLICATION
Wednesday, August 2, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 2, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, August 15, 2017PUBLISHED FOR OPPOSITION
Tuesday, October 31, 2017REGISTERED-PRINCIPAL REGISTER
Friday, November 17, 2017NOTIFICATION PROCESSED BY IB
Wednesday, January 31, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, February 7, 2018GENERIC MADRID TRANSACTION CREATED
Wednesday, February 7, 2018GENERIC MADRID TRANSACTION SENT TO IB
Friday, April 13, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, June 22, 2018CORRECTION TRANSACTION RECEIVED FROM IB
Thursday, July 19, 2018CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Monday, July 23, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 23, 2018CORRECTION UNDER SECTION 7 - PROCESSED
Saturday, March 23, 2019PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Tuesday, April 2, 2019INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Friday, October 16, 2020CHANGE OF OWNER RECEIVED FROM IB
Friday, May 17, 2024CANCELLED SECTION 71
Saturday, January 18, 2025TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Monday, April 7, 2025TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, April 7, 2025INVALIDATION PROCESSED
Saturday, April 26, 2025TOTAL INVALIDATION PROCESSED BY THE IB

Related Keywords

santavac namely substances diseases vaccines oncological treatment prevention preparations pharmaceutical manufacture